DI DOMENICO, FABIO

DI DOMENICO, FABIO  

DIPARTIMENTO DI SCIENZE BIOCHIMICHE "ALESSANDRO ROSSI FANELLI"  

Mostra prodotti
Risultati 1 - 20 di 120 (tempo di esecuzione: 0.035 secondi).
Titolo Data di pubblicazione Autore(i) File
Aberrant crosstalk between insulin signaling and mTOR in young Down syndrome individuals revealed by neuronal-derived extracellular vesicles 2021 Perluigi, M.; Picca, A.; Montanari, E.; Calvani, R.; Marini, F.; Matassa, R.; Tramutola, A.; Villani, A.; Familiari, G.; Domenico, F. D.; Butterfield, D. A.; Oh, K. J.; Marzetti, E.; Valentini, D.; Barone, E.
Aberrant insulin signaling in Alzheimer's disease: current knowledge 2015 Bedse, Gaurav; DI DOMENICO, Fabio; Serviddio, Gaetano; Cassano, Tommaso
Aberrant protein phosphorylation in Alzheimer disease brain disturbs pro-survival and cell death pathways 2016 Perluigi, Marzia; Barone, Eugenio; DI DOMENICO, Fabio; Butterfield, D. A.
Activation of p53 in down syndrome and in the ts65dn mouse brain is associated with a pro-apoptotic phenotype 2016 Tramutola, Antonella; Pupo, Gilda; DI DOMENICO, Fabio; Barone, Eugenio; Arena, Andrea; Lanzillotta, Chiara; Broekaart, Diede; Blarzino, Carla; Head, Elizabeth; Butterfield, D. Allan; Perluigi, Marzia
Advanced glycation end products in diabetic patients with optimized glycaemic control and their effects on endothelial reactivity: possible implications in venous graft failure 2009 Massimo, Chello; Cristiano, Spadaccio; Mario, Lusini; Elvio, Covino; Blarzino, Carla; Federico De, Marco; DI DOMENICO, Fabio; Coccia, Raffaella
Alteration of mTOR signaling occurs early in the progression of Alzheimer disease (AD): analysis of brain from subjects with pre-clinical AD, amnestic mild cognitive impairment and late-stage AD 2015 Tramutola, Antonella; Triplett, Judy C.; DI DOMENICO, Fabio; Niedowicz, Dana M.; Murphy, Michael P.; Coccia, Raffaella; Perluigi, Marzia; Butterfield, D. Allan
The anti-diabetic drug metformin rescues aberrant mitochondrial activity and restrains oxidative stress in a female mouse model of rett syndrome 2020 Zuliani, Ilaria; Urbinati, Chiara; Valenti, Daniela; Cristina Quattrini, Maria; Medici, Vanessa; Cosentino, Livia; Pietraforte, Donatella; DI DOMENICO, Fabio; Perluigi, Marzia; Anna Vacca, Rosa; De Filippis, Bianca
Antioxidants in cervical cancer: Chemopreventive and chemotherapeutic effects of polyphenols 2012 DI DOMENICO, Fabio; C., Foppoli; Coccia, Raffaella; Perluigi, Marzia
Atorvastatin treatment in a dog preclinical model of Alzheimer's disease leads to up-regulation of haem oxygenase-1 and is associated with reduced oxidative stress in brain 2012 D., Butterfield; Barone, Eugenio; DI DOMENICO, Fabio; G., Cenini; R., Sultana; M., Murphy; C., Mancuso; E., Head
Autoantibodies profile in matching CSF and serum from AD and aMCI patients: potential pathogenic role and link to oxidative damage 2016 DI DOMENICO, Fabio; Pupo, Gilda; Giraldo, Esther; Lloret, Ana; Badia, Mari Carmen; Schinina', Maria Eugenia; Giorgi, Alessandra; Butterfield, D. Allan; Vina, Jose; Perluigi, Marzia
Bach1 overexpression in down syndrome correlates with the alteration of the ho-1/bvr-a system: insights for transition to Alzheimer's disease 2015 Di Domenico, Fabio; Pupo, Gilda; Mancuso, C; Barone, Eugenio; Paolini, F; Arena, Andrea; Blarzino, Carla; Schmitt, Fa; Head, E; Butterfield, Da; Perluigi, Marzia
Basal brain oxidative and nitrative stress levels are finely regulated by the interplay between superoxide dismutase 2 and p53 2015 Barone, Eugenio; Cenini, Giovanna; DI DOMENICO, Fabio; Noel, Teresa; Wang, Chi; Perluigi, Marzia; Daret K., S. t. Clair; Butterfield, D. Allan
Biliverdin reductase--a protein levels and activity in the brains of subjects with Alzheimer disease and mild cognitive impairment 2011 Barone, Eugenio; DI DOMENICO, Fabio; Cenini, G; Sultana, R; Cini, Chiara; Preziosi, P; Perluigi, Marzia; Mancuso, C; Butterfield, Da
Biliverdin Reductase-A correlates with inducible nitric oxide synthasein in atorvastatin treated aged canine brain. 2013 DI DOMENICO, Fabio; Perluigi, Marzia; Barone, Eugenio
Biliverdin reductase-A impairment links brain insulin resistance with increased Aβ production in an animal model of aging: implications for Alzheimer disease 2018 Triani, F; Tramutola, A; Di Domenico, F; Sharma, N; Butterfield, Da; Head, E; Perluigi, M; Barone, E
Biliverdin reductase-A mediates the beneficial effects of intranasal insulin in Alzheimer disease 2019 Barone, E; Tramutola, A; Triani, F; Calcagnini, S; Di Domenico, F; Ripoli, C; Gaetani, S; Grassi, C; Butterfield, Da; Cassano, T; Perluigi, M
Biliverdin reductase-A: a novel drug target for atorvastatin in a dog pre-clinical model of Alzheimer disease 2012 Barone, Eugenio; C., Mancuso; DI DOMENICO, Fabio; R., Sultana; M. P., Murphy; E., Head; D. A., Butterfield
Borsa per soggiorno all'estero 2009 DI DOMENICO, Fabio
Brain insulin resistance triggers early onset Alzheimer disease in Down syndrome 2020 Tramutola, A.; Lanzillotta, C.; Di Domenico, F.; Head, E.; Butterfield, D. A.; Perluigi, M.; Barone, E.
Broad kinase inhibition mitigates early neuronal dysfunction in tauopathy 2021 Koren, Shon A; Hamm, Matthew J; Cloyd, Ryan; Fontaine, Sarah N; Chishti, Emad; Lanzillotta, Chiara; Rodriguez-Rivera, Jennifer; Ingram, Alexandria; Bell, Michelle; Galvis-Escobar, Sara M; Zulia, Nicholas; Di Domenico, Fabio; Duong, Duc; Seyfried, Nicholas T; Powell, David; Vandsburger, Moriel; Frolinger, Tal; Hartz, Anika M S; Koren, John; Axten, Jeffrey M; Laping, Nicholas J; Abisambra, Jose F